Relmada Therapeutics Inc. (4E2) Forecast & Analyst Ratings

Munich

Currency in EUR

4.06

0.00 (0.00%)

Real-time Data

06:00 AM

Day's Range

4.06

52 wk Range

0.5350

6.45

Date	Firm	Action	Rating
Jun 18, 2026	HC Wainwright & Co.	Initiates coverage	Buy
Mar 24, 2026	Piper Sandler	Initiates coverage	Overweight
Mar 20, 2026	Mizuho	Maintains	Outperform
Mar 02, 2026	LUCID CAPITAL MARKETS	Initiates coverage	Buy
Jan 23, 2026	Leerink Partners	Upgrade	Market Perform → Outperform
Dec 22, 2025	Jefferies	Initiates coverage	Buy
Nov 19, 2025	Mizuho	Upgrade	Neutral → Outperform
Dec 05, 2024	Mizuho	Downgrade	Outperform → Neutral
Dec 04, 2024	Leerink Partners	Downgrade	Outperform → Market Perform
Jun 05, 2024	Goldman Sachs	Downgrade	Neutral → Sell

Items per row:

1-10 of 26

Date	Time	EPS Estimate	EPS Actual	Difference	Surprise PRC
2026-06-01	-	2.28	3.23	+0.95	‪+41.67%‬
2026-03-05	-	0.67	0.57	-0.10	‪-14.93%‬
2026-02-13	-	0.44	0.50	+0.06	‪+13.64%‬
2025-11-10	-	13.81	13.10	-0.71	‪-5.14%‬
2025-09-23	-	50.68	48.71	-1.97	‪-3.89%‬

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated: Aug 24, 2026, 06:00 AM

Stocks news